87 results on '"Freeman, James"'
Search Results
2. Feasibility of Amulet occluder implantation after failed left atrial appendage occlusion attempt: Insights from the EMERGE LAA postapproval study
3. Intracardiac vs Transesophageal Echocardiography for Left Atrial Appendage Occlusion With Watchman FLX in the U.S.
4. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis
5. Left ventricular lead implantation failure in an unselected nationwide cohort
6. Variation in hospital use of cardiac resynchronization therapy-defibrillator among eligible patients and association with clinical outcomes
7. Qualitative and quantitative detection of SARS-CoV-2 antibodies from dried blood spots
8. Impact of Preprocedure Imaging for Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry
9. SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure
10. SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure
11. SCAI/HRS expert consensus statement on transcatheter left atrial appendage closure
12. Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation
13. Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry
14. Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry
15. Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: A survey analysis of stakeholder practices, needs, and barriers
16. Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation
17. Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathy
18. Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients
19. Analytical characterization of the SARS-CoV-2 EURM-017 reference material
20. Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry)
21. Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial
22. Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator Implantation
23. Risk of COVID-19 infection after cardiac electrophysiology procedures
24. Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)
25. Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019
26. Predictors of Cardiac Perforation With Catheter Ablation of Atrial Fibrillation
27. Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic Medications
28. Digoxin Use and Associated Adverse Events Among Older Adults
29. B-40 | Safety and Efficacy of Combining Left Atrial Appendage Occlusion With Another Cardiac Procedure
30. Contemporary Procedural Complications, Hospitalizations, and Emergency Visits After Catheter Ablation for Atrial Fibrillation
31. Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation
32. Performance evaluation of four 25-hydroxyvitamin D assays to measure 25-hydroxyvitamin D2
33. Cutting the Cord: Time for Leadless Pacemakers to Untether Post-TAVR Patients?
34. A GHS-consistent approach to health hazard classification of petroleum substances, a class of UVCB substances
35. Use of Evidence-based Cardiac Prevention Therapy Among Outpatients with Atrial Fibrillation
36. Effectiveness of β-Blockers in Heart Failure With Left Ventricular Systolic Dysfunction and Chronic Kidney Disease
37. Effectiveness of Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy in Heart Failure
38. PO-01-021 ACCURACY OF IMPLANTABLE LOOP RECORDERS: A MULTI-CENTRE, MULTI-DEVICE COMPARISON OF FALSE POSITIVE ALERT BURDEN IN REMOTE TRANSMISSIONS
39. MP-470550-005 FEASIBILITY OF AMULET IMPLANTATION AFTER FAILED LAAO ATTEMPT: INSIGHTS FROM THE EMERGE LAA POST-APPROVAL STUDY
40. MP-470549-003 IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR BATTERY LONGEVITY VARIATION BY MANUFACTURER AND DEVICE TYPE
41. PO-06-044 IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR BATTERY LONGEVITY VARIATION BY MANUFACTURER AND DEVICE TYPE
42. PO-06-030 FALSE-POSITIVE ILR TRANSMISSION BURDEN: A MULTI-CENTRE COMPARISON BETWEEN DEVICES AND ALGORITHMS
43. Cost-effectiveness of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy
44. Asphalt fume dermal carcinogenicity potential: II. Initiation–promotion assay of Type III built-up roofing asphalt
45. Asphalt fume dermal carcinogenicity potential: I. dermal carcinogenicity evaluation of asphalt (bitumen) fume condensates
46. Effect of whole-body vibration on bone properties in aging mice
47. TCT-33 Racial Disparities in the Utilization and Outcomes of LAA Occlusion Using Watchman FLX: A SURPASS analysis of the NCDR LAAO Registry
48. Smad4-dependent TGF-β Signaling Suppresses RON Receptor Tyrosine Kinase-dependent Motility and Invasion of Pancreatic Cancer Cells
49. CE-452771-4 OUTCOMES WITH DIFFERENT POSTPROCEDURAL ANTITHROMBOTIC THERAPY REGIMENS FOLLOWING LEFT ATRIAL APPENDAGE OCCLUSION
50. CE-452771-3 LEFT ATRIAL APPENDAGE OCCLUSION WITH THE WATCHMAN FLX AND CONCOMITANT CATHETER ABLATION PROCEDURES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.